209 related articles for article (PubMed ID: 19756360)
1. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.
Bazan SB; de Alencar Muniz Chaves A; Aires KA; Cianciarullo AM; Garcea RL; Ho PL
Arch Virol; 2009; 154(10):1609-17. PubMed ID: 19756360
[TBL] [Abstract][Full Text] [Related]
2. Production of L1 protein from different types of HPV in Pichia pastoris using an integrative vector.
Coimbra EC; Gomes FB; Campos JF; D'arc M; Carvalho JC; Mariz FC; Jesus AL; Stocco RC; Beçak W; Freitas AC
Braz J Med Biol Res; 2011 Dec; 44(12):1209-14. PubMed ID: 22030867
[TBL] [Abstract][Full Text] [Related]
3. Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.
Hanumantha Rao N; Baji Babu P; Rajendra L; Sriraman R; Pang YY; Schiller JT; Srinivasan VA
Vaccine; 2011 Oct; 29(43):7326-34. PubMed ID: 21803095
[TBL] [Abstract][Full Text] [Related]
4. Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter.
Mariz FC; Coimbra EC; Jesus AL; Nascimento LM; Torres FA; Freitas AC
Biomed Res Int; 2015; 2015():594120. PubMed ID: 26090426
[TBL] [Abstract][Full Text] [Related]
5. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
6. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M
Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
[TBL] [Abstract][Full Text] [Related]
8. Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris.
Jiang Z; Tong G; Cai B; Xu Y; Lou J
Protein Expr Purif; 2011 Dec; 80(2):203-10. PubMed ID: 21821128
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles.
Gupta G; Glueck R; Rishi N
Biologicals; 2017 Mar; 46():11-22. PubMed ID: 28012703
[TBL] [Abstract][Full Text] [Related]
10. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.
Aires KA; Cianciarullo AM; Carneiro SM; Villa LL; Boccardo E; Pérez-Martinez G; Perez-Arellano I; Oliveira ML; Ho PL
Appl Environ Microbiol; 2006 Jan; 72(1):745-52. PubMed ID: 16391114
[TBL] [Abstract][Full Text] [Related]
11. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
Matić S; Rinaldi R; Masenga V; Noris E
BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
[TBL] [Abstract][Full Text] [Related]
12. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
13. [Production of human papillomavirus type 16 virus-like particles and its immunogenicity].
Wei MX; Li SW; Huang B; Shen WT; Su YZ; Zhang CH; Gu Y; Du HL; Zhang J; Xia NS
Bing Du Xue Bao; 2009 Jul; 25(4):245-50. PubMed ID: 19769155
[TBL] [Abstract][Full Text] [Related]
14. Expression of the bovine papillomavirus type 1, 2 and 4 L1 genes in the yeast Pichia pastoris.
Jesus AL; Mariz FC; Souza HM; Cordeiro MN; Coimbra EC; Leitão MC; Nascimento LM; Stocco RC; Beçak W; Freitas AC
Genet Mol Res; 2012 Aug; 11(3):2598-607. PubMed ID: 22869085
[TBL] [Abstract][Full Text] [Related]
15. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
16. Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania.
Bolhassani A; Muller M; Roohvand F; Motevalli F; Agi E; Shokri M; Rad MM; Hosseinzadeh S
Hum Vaccin Immunother; 2014; 10(12):3499-508. PubMed ID: 25668661
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.
Windram OP; Weber B; Jaffer MA; Rybicki EP; Shepherd DN; Varsani A
Arch Virol; 2008; 153(3):585-9. PubMed ID: 18175039
[TBL] [Abstract][Full Text] [Related]
18. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
Park MA; Kim HJ; Kim HJ
Protein Expr Purif; 2008 May; 59(1):175-81. PubMed ID: 18343683
[TBL] [Abstract][Full Text] [Related]
19. Comparing cytosolic expression to peroxisomal targeting of the chimeric L1/L2 (ChiΔH-L2) gene from human papillomavirus type 16 in the methylotrophic yeasts Pichia pastoris and Hansenula polymorpha.
Smith JJ; Burke A; Bredell H; van Zyl WH; Görgens JF
Yeast; 2012 Sep; 29(9):385-93. PubMed ID: 22926974
[TBL] [Abstract][Full Text] [Related]
20. The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response.
Bissa M; Zanotto C; Pacchioni S; Volonté L; Venuti A; Lembo D; De Giuli Morghen C; Radaelli A
Antiviral Res; 2015 Apr; 116():67-75. PubMed ID: 25660110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
